ACE index to predict steroid response in severe colitis
Part of Digestive system, Immune system & allergy clinical trials.
This trial looks at a simple score (based on your albumin, CRP, and colonoscopy findings) to see which patients with severe ulcerative colitis will respond to IV steroids. The goal is to make treatment decisions faster and more personalized.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have ulcerative colitis (either newly diagnosed or a current flare-up).
- You do not have an active infection with CMV or C. diff.
- You are not being admitted to the hospital for a planned (elective) reason.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial will check if two substances in the blood, Oncostatin M and Galectin 3, can help doctors diagnose and tell how active ulcerative colitis is. It includes new patients with ulcerative colitis and healthy people for comparison.
This study uses a special AI system that analyzes images from a colonoscopy to help doctors better understand how active your ulcerative colitis is and predict how it might progress. If you are scheduled for a routine colonoscopy, this AI tool may help your doctor make more precise treatment decisions.
This trial tests if adding upadacitinib (a pill) to standard steroid treatment helps people with a severe flare of ulcerative colitis feel better faster. You may qualify if you are having frequent bloody stools and signs of serious inflammation, and you haven't tried upadacitinib before.
This trial uses a gentle ultrasound scan (on the outside of the body) to see how well treatment is working during a moderate to severe flare of ulcerative colitis. It aims to find out if this painless test can predict recovery and help guide care without needing a telescope exam (endoscopy).
This study compares different sequences of medicines for treating severe ulcerative colitis flares in the hospital. It aims to find the best way to get your symptoms under control and help you feel better faster.
This study tests whether a substance in your urine can help measure how active your ulcerative colitis is. Researchers hope this simple urine test might become a useful tool to track your disease without more invasive procedures.
Hear when a new Early Detection of Complication of Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.